OncoSil Medical files for US FDA approval for specialist device
OncoSil Medical has hit a key milestone in its plans to commercialise its unique OncoSil device for the treatment of dCCA.
Market Cap $201.2M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.10pm 03/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 65.0¢ | Day High | 68.8¢ | Day Low | 65.0¢ | |||
| Daily Volume | 238934 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 67.0¢ | 2869 | 0 | 69.0¢ | 14000 | |
Directors & Senior Management
| Mr. Alan David Stephen Armstrong | Company Secretary |
| Mr. Brent Walsh | Independent Non-Executive Director |
| Mr. Ian Plimer | Independent Non-Executive Director |
| Mr. Mark Hine | Independent Non-Executive Director |
| Mr. Michael Worcester | Chief Financial Officer |
| Mr. Patrick Christopher Andrew Walta | Executive Chairman |
| Mr. Stephen Woodham | Non-Executive Director |
Data source: ADVFN
